Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The investigators propose to treat newly diagnosed, hyperfiltering T2DM patients with or without microalbuminuria with dapagliflozin or metformin for 4 months. The metformin-treated group will serve as controls for improved glycemic control, since the investigators have shown that insulin therapy to normalize A1c reduces hyperfiltration and kidney size in T1DM patients.
Epistemonikos ID: 634186f1bda3b02060244bddfb705a17cd4d31cb
First added on: May 17, 2024